{"schema_version":"secwatch.filing_event.v1","accession":"0001839882-23-026088","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.906713+00:00","generated_at":"2026-06-10T06:52:06.963376+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tonix Pharmaceuticals prices $4.5M public offering of common stock and warrants","bullets":["Offering comprises 9M shares, 9M Series A warrants (5-yr, $0.50 exercise), 9M Series B warrants (1-yr, $0.50); combined price $0.50 per unit.","Gross proceeds ~$4.5M; net proceeds for working capital, manufacturing & R&D facilities, and product acquisition/licensing.","Placement agents A.G.P./Alliance Global Partners and Brookline Capital Markets; 7.0% cash fee plus up to $100k expense reimbursement.","Closing expected on or about October 3, 2023, subject to customary closing conditions.","Directors and officers subject to 60-day lock-up on sale of securities post-closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001839882-23-026088","json":"https://secwatch.observer/filing/0001839882-23-026088.json","markdown":"https://secwatch.observer/filing/0001839882-23-026088.md","text":"https://secwatch.observer/filing/0001839882-23-026088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/tnxp-8k_092823.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:52:06.963376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"37ca1a0f200f2c533647e3fa69d0e6d72968406b","claim":"Tonix Pharmaceuticals Holding Corp. entered into Placement Agent Agreement with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (effective 2023-09-28).","evidence_excerpt":"On September 28, 2023, the Company also entered into a placement agent agreement (the “Placement Agent Agreement”) with A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC (the “Placement Agents”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners and Brookline Capital Markets, a division of Arcadia Securities, LLC"},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"},{"claim_id":"83d6b748e9ae33f6e9462fadb7c904074acda8fa","claim":"Tonix Pharmaceuticals Holding Corp. entered into Securities Purchase Agreement with certain institutional investors valued at approximately $4.5 million (effective 2023-09-28).","evidence_excerpt":"On September 28, 2023, Tonix Pharmaceuticals Holding Corp. (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Purchasers”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223026088/0001839882-23-026088-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"approximately $4.5 million"},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}